Stock Surge: RxSight Inc (RXST) Closes at 34.59, Marking a 2.76 Increase/Decrease

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, RxSight Inc (NASDAQ: RXST) closed at $34.59 up 2.76% from its previous closing price of $33.66. In other words, the price has increased by $2.76 from its previous closing price. On the day, 0.69 million shares were traded. RXST stock price reached its highest trading level at $34.885 during the session, while it also had its lowest trading level at $33.78.

Ratios:

For a deeper understanding of RxSight Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.71 and its Current Ratio is at 12.67. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 20, 2024, Downgraded its rating to Hold and sets its target price to $40 from $65 previously.

On December 11, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $56 to $42.

On December 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $52.UBS initiated its Buy rating on December 06, 2024, with a $52 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 29 ’24 when Goldshleger Ilya sold 3,105 shares for $46.08 per share. The transaction valued at 143,078 led to the insider holds 42,246 shares of the business.

ILYA GOLDSHLEGER bought 3,105 shares of RXST for $143,078 on Nov 29 ’24. On Nov 26 ’24, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,782 shares for $45.88 each. As a result, the insider received 173,518 and left with 10,902 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 1394132608 and an Enterprise Value of 1130832256. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.58 while its Price-to-Book (P/B) ratio in mrq is 5.02. Its current Enterprise Value per Revenue stands at 8.814 whereas that against EBITDA is -32.336.

Stock Price History:

Over the past 52 weeks, RXST has reached a high of $66.54, while it has fallen to a 52-week low of $33.03. The 50-Day Moving Average of the stock is -24.01%, while the 200-Day Moving Average is calculated to be -32.71%.

Shares Statistics:

For the past three months, RXST has traded an average of 606.58K shares per day and 1206040 over the past ten days. A total of 40.25M shares are outstanding, with a floating share count of 38.27M. Insiders hold about 5.05% of the company’s shares, while institutions hold 84.52% stake in the company. Shares short for RXST as of 1732838400 were 2582933 with a Short Ratio of 4.26, compared to 1730332800 on 2743651. Therefore, it implies a Short% of Shares Outstanding of 2582933 and a Short% of Float of 6.72.

Most Popular